drugset / Trial / NCT00563225
20 Week Bridging Study in Type II DM
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A multicenter, non-comparative, one arm, open, phase III study to evaluate the efficacy and safety of insulin glargine on subjects with Type 2 Diabetes Mellitus
Timeline
- Start
- 2002-10
- Primary completion
- —
- Completion
- 2004-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin glargine | Protein / enzyme biologic | — | Subcutaneous |